MONITORING HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS BY ACTIVATED CLOTTING TIME

被引：0
|
作者：
BERG, E
STENBJERG, S
ALBRECHTSEN, OK
机构：
来源：
JOURNAL OF EXTRA-CORPOREAL TECHNOLOGY | 1979年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：229 / 235
页数：7
相关论文
共 50 条
  • [1] ACTIVATED CLOTTING TIME AND HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS
    SWAANENBURG, JCJM
    BRENKEN, U
    BAKKER, HAM
    CLINICAL CHEMISTRY, 1990, 36 (06) : 975 - 975
  • [2] CLINICAL-EXPERIENCE WITH THE ACTIVATED CLOTTING TIME FOR THE CONTROL OF HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS
    AKL, BF
    VARGAS, GM
    NEAL, J
    ROBILLARD, J
    KELLY, P
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1980, 79 (01): : 97 - 102
  • [3] MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, H
    YACOUB, M
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1025 - 1025
  • [4] Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass
    Mochizuki, T
    Olson, PJ
    Szlam, F
    Ramsay, JG
    Levy, JH
    ANESTHESIA AND ANALGESIA, 1998, 87 (04): : 781 - 785
  • [5] GUIDELINES FOR MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, HC
    YACOUB, M
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 104 (01): : 211 - 212
  • [6] HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS IN MAN - USE OF FLUOROGENIC HEPARIN ASSAY TO VALIDATE ACTIVATED CLOTTING TIME
    HUGHES, DR
    FAUST, RJ
    DIDISHEIM, P
    TINKER, JH
    ANESTHESIA AND ANALGESIA, 1982, 61 (02): : 189 - 190
  • [7] LACK OF CORRELATION BETWEEN ACTIVATED CLOTTING TIME AND PLASMA HEPARIN DURING CARDIOPULMONARY BYPASS
    CULLIFORD, AT
    GITEL, SN
    STARR, N
    THOMAS, ST
    BAUMANN, FG
    WESSLER, S
    SPENCER, FC
    ANNALS OF SURGERY, 1981, 193 (01) : 105 - 111
  • [8] Measurement of activated clotting time and whole blood heparin concentration during cardiopulmonary bypass
    Takashi Watanabe
    Kazuaki Shirota
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998, 46 (6): : 530 - 530
  • [9] THE ROLE OF THE ACTIVATED CLOTTING TIME IN HEPARIN ADMINISTRATION AND NEUTRALIZATION FOR CARDIOPULMONARY BYPASS
    ESPOSITO, RA
    CULLIFORD, AT
    COLVIN, SB
    THOMAS, SJ
    LACKNER, H
    SPENCER, FC
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 85 (02): : 174 - 185
  • [10] Extrinsic pathway-associated activated clotting time for anticoagulation monitoring during cardiopulmonary bypass
    Gu, YJ
    Huyzen, RJ
    vanOeveren, W
    ANESTHESIA AND ANALGESIA, 1996, 83 (02): : 433 - 433
12345